The global calcium supplements market is valued at US$6.30 billion in 2026 and is projected to reach US$8.40 billion by 2033, growing at a CAGR of 4.2%.
Growth is driven by increasing osteoporosis prevalence, ageing populations, healthcare-supported supplementation programs, and expanding micronutrient initiatives.
Adult Calcium Supplements lead with 80.0% market share due to strong demand for bone health maintenance and osteoporosis prevention.
North America leads with 38.0% market share, supported by high osteoporosis awareness, strong supplement adoption, and advanced retail distribution networks.
Key opportunities include personalized nutrition, bone health monitoring solutions, and subscription-based supplement programs.